The patient is at the heart of what we do.
PhaseBio is developing specialized, highly innovative therapies for patients with serious cardiovascular diseases. We are determined to overcome the lack of new treatment options for cardiovascular disease and provide superior outcomes for patients and healthcare systems. Driven by high-quality science, we leverage our team’s deep expertise to rapidly develop and commercialize our pipeline of unique medicines.